{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06458530",
            "orgStudyIdInfo": {
                "id": "Pro00110021_2"
            },
            "organization": {
                "fullName": "Impactiv, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Examining the Effects of Vivo on Physical Function and Glycemic Level in Sedentary Older With Prediabetes.",
            "officialTitle": "Vivo Prediabetes Study: Evaluating the Effect of Participating in Vivo on Physical Function and Glycemic Level in Sedentary Older With Prediabetes",
            "therapeuticArea": [
                "Endocrinology",
                "Other"
            ],
            "study": "examining-the-effects-of-vivo-on-physical-function-and-glycemic-level-in-sedentary-older-with-prediabetes"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07-09",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-08-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-08-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-06-10",
            "studyFirstSubmitQcDate": "2024-06-10",
            "studyFirstPostDateStruct": {
                "date": "2024-06-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-26",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Eric Levian",
                "investigatorTitle": "CEO",
                "investigatorAffiliation": "Impactiv, Inc."
            },
            "leadSponsor": {
                "name": "Impactiv, Inc.",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Duke University",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a 12-week randomized, controlled trial that seeks to examine the effect of Vivo on 1) change in lower extremity strength defined as number of chair stands done in 30 seconds and 2) change in average glycemic level (HbA1c) compared to a wait list control.",
            "detailedDescription": "This is a 12-week randomized, controlled trial that seeks to examine the effect of Vivo on 1) change in lower extremity strength defined as number of chair stands done in 30 seconds and 2) change in average glycemic level (HbA1c) compared to a wait list control. After informed consent and baseline assessments, up to 90 individuals will be randomized in one of two arms: 1) Vivo intervention or 2) waitlist control. Participants in the Vivo 2.0 intervention arm will meet virtually twice a week with their small group and certified trainer for 45 minutes over a 12-week period. Participants will be men and women, \u226560 years old, sedentary, with prediabetes and low function. All participants will undergo baseline and 12-week assessments"
        },
        "conditionsModule": {
            "conditions": [
                "PreDiabetes",
                "Older Adult",
                "Muscle Loss",
                "Muscle Weakness"
            ],
            "keywords": [
                "Virtual Exercise Intervention",
                "Strength training",
                "Older Adult",
                "Prediabetes",
                "Muscle strength",
                "Small group training"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "maskingDescription": "The PI will be masked to randomization assignment.",
                    "whoMasked": [
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 90,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Vivo intervention",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will meet virtually twice a week for 12 weeks with their small group and certified trainer for 45 minutes.",
                    "interventionNames": [
                        "Behavioral: Vivo"
                    ]
                },
                {
                    "label": "Waitlist control",
                    "type": "NO_INTERVENTION",
                    "description": "Participants randomized to this arm will be asked to maintain their baseline physical activity for 12-weeks. They will be scheduled for the baseline and 12-week assessment and following the 12-week assessment, they will be offered enrollment into Vivo."
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Vivo",
                    "description": "Participants will meet virtually twice a week with their small group and certified trainer for 45 minutes exercise sessions for a 12-week period.",
                    "armGroupLabels": [
                        "Vivo intervention"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Lower body strength",
                    "description": "Lower body strength measured by the 30-second chair stand",
                    "timeFrame": "baseline and 12 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Hemoglobin A1C (HbA1C)",
                    "description": "Hemoglobin A1C (HbA1C) measure during clinic assessment",
                    "timeFrame": "baseline and 12 weeks"
                },
                {
                    "measure": "Balance",
                    "description": "Static Balance Score of the SPPB. Sore 0-4 depending on the combined results of side by side, semi-tandem, and tandem stand tests.",
                    "timeFrame": "baseline and 12 weeks"
                },
                {
                    "measure": "Physical Activity Level",
                    "description": "Average step count using Garmin Fitness Tracker",
                    "timeFrame": "baseline and 12 weeks"
                },
                {
                    "measure": "Aerobic Endurance",
                    "description": "Measured by the 2-minute step test for aerobic endurance",
                    "timeFrame": "baseline and 12 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u2265 60 years\n* Ambulatory and community-dwelling\n* Diagnosis of Pre-diabetes within prior 12 months: fasting glucose between 100 to 126 OR HbA1c between 5.7 and 6.4%\n* Low functioning: 1) able to do at least 1 chair stand and 2) number of chair stands done in 30 seconds is below criterion-referenced fitness standards for maintaining physical independence for age and gender\n* Sedentary: less than 150 minutes of moderate physical activity OR less than 60 minutes of vigorous physical activity per week\n* Have not engaged in resistance training for at least 6 months prior to enrollment\n* Access to WiFi in defined exercise space\n\nExclusion Criteria:\n\n* Inability to complete physical function assessment\n* Use of antidiabetic medications\n* Use of testosterone supplement or replacement\n* Clinical disorder precluding/interfering with participation of assessments\n\n  * Unstable angina, arrhythmia, uncontrolled hypertension\n  * End Stage Renal Disease on Hemodialysis\n  * Lower extremity amputation or paralysis\n  * Neurological condition causing functional or pronounced cognitive impairments\n  * Active malignancy except for non-melanomatous skin cancers\n* Weight instability (defined as gain or loss of \u226510% over the last 6 months)\n* Unable to provide consent",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "60 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Recruiter",
                    "role": "CONTACT",
                    "phone": "919-660-7507",
                    "email": "VivoPrediabetes@duke.edu"
                }
            ],
            "locations": [
                {
                    "facility": "Duke University Medical Center",
                    "status": "RECRUITING",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27710",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kathryn Starr, RD, PHD",
                            "role": "CONTACT",
                            "phone": "919-660-7571",
                            "email": "kathryn.starr@duke.edu"
                        },
                        {
                            "name": "Johanna Johnson, MS",
                            "role": "CONTACT",
                            "phone": "(919) 660-6766",
                            "email": "johanna.johnson@duke.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000018908",
                    "term": "Muscle Weakness"
                },
                {
                    "id": "D000011236",
                    "term": "Prediabetic State"
                },
                {
                    "id": "D000018149",
                    "term": "Glucose Intolerance"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000006943",
                    "term": "Hyperglycemia"
                },
                {
                    "id": "D000009135",
                    "term": "Muscular Diseases"
                },
                {
                    "id": "D000009140",
                    "term": "Musculoskeletal Diseases"
                },
                {
                    "id": "D000020879",
                    "term": "Neuromuscular Manifestations"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14117",
                    "name": "Prediabetic State",
                    "asFound": "Prediabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20295",
                    "name": "Glucose Intolerance",
                    "asFound": "Prediabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20944",
                    "name": "Muscle Weakness",
                    "asFound": "Muscle Weakness",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13204",
                    "name": "Paresis",
                    "relevance": "LOW"
                },
                {
                    "id": "M4554",
                    "name": "Asthenia",
                    "relevance": "LOW"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9994",
                    "name": "Hyperglycemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M12092",
                    "name": "Muscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12097",
                    "name": "Musculoskeletal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22619",
                    "name": "Neuromuscular Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC05",
                    "name": "Musculoskeletal Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4854",
                    "name": "Benzocaine",
                    "relevance": "LOW"
                },
                {
                    "id": "T433",
                    "name": "Tannic Acid",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Ot",
                    "name": "Other Dietary Supplements"
                }
            ]
        }
    },
    "hasResults": false
}